These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 16313051

  • 1. [Use of low molecular weight heparin (Clexane) together with selective COX-2 inhibitor (Dynastat--once or twice per day)].
    Tablov B, Ruseva A, Tablov V, Popov I, Stoĭkov S.
    Akush Ginekol (Sofiia); 2005; 44(5):31-4. PubMed ID: 16313051
    [Abstract] [Full Text] [Related]

  • 2. [Usage of the new parenteral selective cox-2 inhibitor dynastat in the gynecologic practice].
    Tablov B, Tablov V, Popov I, Stoĭkov S.
    Akush Ginekol (Sofiia); 2006; 45(5):10-3. PubMed ID: 17168490
    [Abstract] [Full Text] [Related]

  • 3. Safety of low-dose subcutaneous enoxaparin for the prevention of venous thromboembolism after primary intracerebral haemorrhage.
    Tetri S, Hakala J, Juvela S, Saloheimo P, Pyhtinen J, Rusanen H, Savolainen ER, Hillbom M.
    Thromb Res; 2008; 123(2):206-12. PubMed ID: 18420258
    [Abstract] [Full Text] [Related]

  • 4. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB, Sin'kov SV, Klevko VA.
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.
    Narin C, Reyhanoglu H, Tülek B, Onoglu R, Ege E, Sarigül A, Yeniterzi M, Durmaz I.
    Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442
    [Abstract] [Full Text] [Related]

  • 6. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H, Videm V, Wahba A, Asberg A, Amundsen T, Bjella L, Dale O, Stenseth R.
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [Abstract] [Full Text] [Related]

  • 7. [The use of low-molecular heparins in reconstructive surgery of ascending aortic aneurysms].
    Aliev MA, Dzhakupov VA, Seĭdalin AO, Mierbekov EM, Kalyshev RS.
    Angiol Sosud Khir; 2004 Jun; 10(3):25-7. PubMed ID: 15622390
    [Abstract] [Full Text] [Related]

  • 8. The management of lichen planus with low-molecular-weight heparin (enoxaparin).
    Akdeniz S, Harman M, Atmaca S, Yaldiz M.
    Int J Clin Pract; 2005 Nov; 59(11):1268-71. PubMed ID: 16236078
    [Abstract] [Full Text] [Related]

  • 9. Serum acute phase protein concentrations after hysterectomy with and without low-molecular-weight heparin thrombosis prophylaxis.
    Maciejczyk-Pencuła M, Polak G, Kotarski J.
    Acta Obstet Gynecol Scand; 2005 Aug; 84(8):752-5. PubMed ID: 16026400
    [Abstract] [Full Text] [Related]

  • 10. Low-molecular-weight heparin as an adjunct to thrombolysis in ST elevation myocardial infarction.
    Quinlan DJ, Eikelboom JW.
    Arch Intern Med; 2009 Jun 22; 169(12):1163-4. PubMed ID: 19546418
    [No Abstract] [Full Text] [Related]

  • 11. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration.
    Schobess R, Düring C, Bidlingmaier C, Heinecke A, Merkel N, Nowak-Göttl U.
    Haematologica; 2006 Dec 22; 91(12):1701-4. PubMed ID: 17145610
    [Abstract] [Full Text] [Related]

  • 12. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study.
    Zezos P, Papaioannou G, Nikolaidis N, Patsiaoura K, Papageorgiou A, Vassiliadis T, Giouleme O, Evgenidis N.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1443-53. PubMed ID: 16669959
    [Abstract] [Full Text] [Related]

  • 13. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
    Omran H, Hammerstingl C, Paar WD, Bonn Registry of Alternative Anticoagulation to Prevent Vascular Events.
    Med Klin (Munich); 2007 Oct 15; 102(10):809-15. PubMed ID: 17928964
    [Abstract] [Full Text] [Related]

  • 14. A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory.
    Marmur JD, Lakhani M, El Rouby S, Cavusoglu E.
    J Invasive Cardiol; 2008 Sep 15; 20(9):449-54. PubMed ID: 18762674
    [Abstract] [Full Text] [Related]

  • 15. [The effect of Clexane (low-molecular-weight heparin) on the hemostatic system and on the incidence of postoperative thrombotic complications in gynecological cancer patients].
    Madzhuga AV, Somonova OV, Kononenko LP, Gorobets ES, Elizarova AL, Astakhova VM.
    Anesteziol Reanimatol; 2000 Sep 15; (2):54-6. PubMed ID: 10833839
    [Abstract] [Full Text] [Related]

  • 16. The safety of low molecular weight heparin therapy during labor.
    Maslovitz S, Many A, Landsberg JA, Varon D, Lessing JB, Kupferminc MJ.
    J Matern Fetal Neonatal Med; 2005 Jan 15; 17(1):39-43. PubMed ID: 15804785
    [Abstract] [Full Text] [Related]

  • 17. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
    Tebbe U.
    Dtsch Med Wochenschr; 2007 Sep 15; 132(39):2033-6. PubMed ID: 17882745
    [No Abstract] [Full Text] [Related]

  • 18. Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement.
    Meurin P, Tabet JY, Weber H, Renaud N, Ben Driss A.
    Circulation; 2006 Jan 31; 113(4):564-9. PubMed ID: 16449734
    [Abstract] [Full Text] [Related]

  • 19. [Rivaroxaban (Xarelto): efficacy and safety].
    Rosencher N, Arnaout L, Chabbouh T, Bellamy L.
    Ann Fr Anesth Reanim; 2008 Dec 31; 27 Suppl 3():S22-7. PubMed ID: 19185784
    [Abstract] [Full Text] [Related]

  • 20. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
    Meister B, Kropshofer G, Klein-Franke A, Strasak AM, Hager J, Streif W.
    Pediatr Blood Cancer; 2008 Feb 31; 50(2):298-303. PubMed ID: 17443678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.